Integrative transcriptomic, genetic, single-cell, and experimental analyses prioritize HILPDA in preeclampsia

Background Preeclampsia (PE) is a major cause of maternal and perinatal morbidity and mortality. Its molecular drivers remain incompletely understood, which limits the development of targeted therapies. This study aimed to prioritize PE-associated candidate genes and characterize their cell type-specific relevance in the placenta. Methods Eight placental transcriptomic datasets were integrated for differential expression analysis and weighted gene co-expression network analysis. Three gradient-boosting algorithms were used to construct PE prediction models. Five additional machine-learning methods were applied for biomarker selection. Mendelian randomization was performed using two independent PE genome-wide association studies. Single-cell RNA sequencing was used to examine cell type-specific expression, transcription factor activity, intercellular communication, trophoblast co-expression networks, virtual gene perturbation, and trophoblast subtypes. The function of the prioritized gene was evaluated in lipopolysaccharide-treated HTR-8/SVneo cells. Connectivity Map screening, molecular docking, and molecular dynamics simulations were used to identify candidate compounds. Results Twenty-two differentially expressed and disease-associated genes were identified. The prediction models showed good performance in the mixed validation dataset, with area under the curve values of 0.841, 0.789, and 0.825 for XGBoost, LightGBM, and GBM, respectively. HILPDA was selected by all five feature-selection methods. Mendelian randomization provided genetic evidence supporting an association between HILPDA expression and PE. Single-cell analysis showed that HILPDA was predominantly expressed in trophoblasts. HILPDA expression was associated with altered trophoblast communication, inflammatory signaling, mitochondrial and translational programs, cell adhesion, and subtype-specific regulatory networks. In LPS-stimulated HTR-8/SVneo cells, HILPDA knockdown partially restored cell migration and VEGF and PlGF expression and reduced inflammatory cytokine expression, NF-κB activation, and apoptosis-related changes. Four compounds, NVP-BEZ235, vanoxerine, NVP-TAE226, and cycloserine, showed favorable predicted interactions with HILPDA. Conclusions HILPDA was identified as a PE-associated candidate by transcriptomic, machine-learning, and genetic analyses and was mainly expressed in trophoblasts at the single-cell level. In LPS-stimulated HTR-8/SVneo cells, HILPDA knockdown attenuated inflammatory and pro-apoptotic responses and partially restored cell migration and angiogenic-factor expression. These findings support further investigation of HILPDA in PE-related trophoblast dysfunction, although its underlying mechanisms and therapeutic relevance require additional validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.1973156
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative transcriptomic, genetic, single-cell, and experimental analyses prioritize HILPDA in preeclampsia

Mengmeng Sang, Zongyu Guan, Jia Ge, Lin Xu et al.
7 links
Frontiers in Immunology
Pregnancy and preeclampsia studies
article

Integrative transcriptomic, genetic, single-cell, and experimental analyses prioritize HILPDA in preeclampsia

Mengmeng Sang, Zongyu Guan, Jia Ge, Lin Xu, Boyu Zhang, Yunzhao Xu
article en

Abstract

Background Preeclampsia (PE) is a major cause of maternal and perinatal morbidity and mortality. Its molecular drivers remain incompletely understood, which limits the development of targeted therapies. This study aimed to prioritize PE-associated candidate genes and characterize their cell type-specific relevance in the placenta. Methods Eight placental transcriptomic datasets were integrated for differential expression analysis and weighted gene co-expression network analysis. Three gradient-boosting algorithms were used to construct PE prediction models. Five additional machine-learning methods were applied for biomarker selection. Mendelian randomization was performed using two independent PE genome-wide association studies. Single-cell RNA sequencing was used to examine cell type-specific expression, transcription factor activity, intercellular communication, trophoblast co-expression networks, virtual gene perturbation, and trophoblast subtypes. The function of the prioritized gene was evaluated in lipopolysaccharide-treated HTR-8/SVneo cells. Connectivity Map screening, molecular docking, and molecular dynamics simulations were used to identify candidate compounds. Results Twenty-two differentially expressed and disease-associated genes were identified. The prediction models showed good performance in the mixed validation dataset, with area under the curve values of 0.841, 0.789, and 0.825 for XGBoost, LightGBM, and GBM, respectively. HILPDA was selected by all five feature-selection methods. Mendelian randomization provided genetic evidence supporting an association between HILPDA expression and PE. Single-cell analysis showed that HILPDA was predominantly expressed in trophoblasts. HILPDA expression was associated with altered trophoblast communication, inflammatory signaling, mitochondrial and translational programs, cell adhesion, and subtype-specific regulatory networks. In LPS-stimulated HTR-8/SVneo cells, HILPDA knockdown partially restored cell migration and VEGF and PlGF expression and reduced inflammatory cytokine expression, NF-κB activation, and apoptosis-related changes. Four compounds, NVP-BEZ235, vanoxerine, NVP-TAE226, and cycloserine, showed favorable predicted interactions with HILPDA. Conclusions HILPDA was identified as a PE-associated candidate by transcriptomic, machine-learning, and genetic analyses and was mainly expressed in trophoblasts at the single-cell level. In LPS-stimulated HTR-8/SVneo cells, HILPDA knockdown attenuated inflammatory and pro-apoptotic responses and partially restored cell migration and angiogenic-factor expression. These findings support further investigation of HILPDA in PE-related trophoblast dysfunction, although its underlying mechanisms and therapeutic relevance require additional validation.

Frontiers in ImmunologyVol. 17
Xuzhou Medical College (CN), Nantong University (CN), Affiliated Hospital of Nantong University (CN), Affiliated Hospital of Xuzhou Medical College (CN)
Nantong University, Science and Technology Project of Nantong City
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon